Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of long non-coding RNA in drug resistance in non-small cell lung cancer.

Thoracic cancer - 1 Jul 2018

Wang Leirong, Ma Leina, Xu Fei, Zhai Wenxin, Dong Shenghua, Yin Ling, Liu Jia, Yu Zhuang

Abstract excerpt

Lung cancer is the leading cause of cancer-associated death, and non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases. Many drugs have been used to treat NSCLC in order to improve patient prognosis. Platinum-based chemotherapy is the first-line treatment for locally advanced or metastatic patients. For patients with activating EGFR mutations, tyrosine kinase inhibitors are the best...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Protein Kinase Inhibitors

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 29726094
DOI: 10.1111/1759-7714.12652
PMCID: PMC6026617

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of long non-coding RNA in drug resistance in non-small cell lung cancer.PMID 29726094Read ↗

Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini ReviewSemantic proximity Read ↗

The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancerSemantic proximity Read ↗

The functional role of long noncoding RNA in resistance to anticancer treatmentSemantic proximity Read ↗

Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancerSemantic proximity Read ↗

Long non-coding RNAs in anti-cancer drug resistanceSemantic proximity Read ↗

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung CancerSemantic proximity Read ↗

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedureSemantic proximity Read ↗

Drug resistance in lung cancerSemantic proximity Read ↗

Regulation of cisplatin resistance in lung cancer by epigenetic mechanismsSemantic proximity Read ↗

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance.Semantic proximity Read ↗

Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation.Semantic proximity Read ↗

Long Noncoding RNAs as Biotargets in Cisplatin-Based Drug ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.